Insider Cluster (3 insiders) ·Filed Aug 31, 2026

TRDA

Entrada Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed28d 22h ago
Insider cluster: 2 insiders, $619K total
Actionable Insight • Neutral

The selling by MPM entities is modest relative to market cap and involves only venture-capital 10% owners, not C-suite executives — this cluster is unlikely to signal material negative information. Monitor for any subsequent 8-K or press release that could explain the selling, but the default expectation is routine portfolio rebalancing by early-stage investors. The historical underperformance of TRDA cluster reports at T+20 suggests the market has not reacted strongly to similar patterns.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+20d ⚠ clustered
TRDA ▼ -10.18% at T+20d
NEUTRAL call ✗ call lost -10.18% · α vs SPY -10.50% · entry $7.07 → $6.35
Next anchor: T+60d in 8w
Latest observation: T+22 -10.58% FF3 residual α
Entry anchored
Aug 31, 04:14 PM ET
via 1-min bar
T+1d
+3.25%
call +3.25% · α +2.81%
$7.30
settled 4w ago
T+5d
+0.57%
call +0.57% · α +0.48%
$7.11
settled 24d ago
T+20d
-10.18%
call -10.18% · α -10.50%
$6.35
settled 3d ago
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

Two 10% owner entities (MPM BioVentures 2014 and 2018) sold a combined 88.5K shares for ~$619K in open-market sales over two days, while the CEO had a routine tax-withholding transaction. The selling is modest at ~0.22% of market cap, and as a cluster of sells by non-C-suite insiders, it carries limited predictive signal per academic literature. The historical calibration shows past TRDA reports have underperformed at T+20 (avg alpha -4%), suggesting caution against over-interpreting this cluster as bearish.

Key Financial Metrics

Direction
selling
Total Value
$619.1K
Insiders
3

Key Facts

  • Two MPM BioVentures entities (10% owners) sold 44,259 shares each on 2026-08-31 at $6.99, totaling ~$618K
  • CEO Doshi Dipal had a routine tax-withholding transaction of 8,724 shares on 2026-09-02 with no open-market activity
  • Total open-market selling of ~$618K represents ~0.22% of TRDA's $284M market cap
  • No C-suite executives engaged in open-market sales; selling is limited to venture capital 10% owners
  • TRDA has 86% analyst bullish rating (5 Strong Buy, 7 Buy) but past cluster reports on this ticker have shown negative T+20 alpha

Financial Impact

Open-market sales of ~$618K by two 10% owner entities, representing ~0.22% of market cap

insider ownership

Risk Factors

  • Venture capital 10% owners may have additional selling pressure if they continue to reduce positions
  • TRDA's small $284M market cap makes it susceptible to disproportionate price moves from any insider selling
  • Historical calibration shows past TRDA reports have negative average alpha at T+20, indicating limited predictive value of cluster signals for this ticker

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TRDA-1788472085124
18 reports for TRDA
Performance horizon
50% Hit rate 2 of 4 directional calls best @ T+60▲ +58.52%May 4, 2026
Filters
Rows
Reports for TRDA — sortable, filterable
TypeNow
Sep 9, 2026
22d ago
Insider Cluster
BEARISH ★ 6/10
$6.42 $6.90▼ −7.48%▼ −7.98%$5.38 (+16.20%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 3/10
$7.17 $6.80▼ −5.16%▼ −4.01%$5.38 (−24.97%)
Aug 31, 2026
4w ago
Insider Cluster
NEUTRAL ★ 4/10
$7.07 $7.11▲ +0.57%▲ +0.48%$5.38 (−23.90%)
Aug 31, 2026
4w ago
Insider Cluster
NEUTRAL ★ 4/10
$7.07 $7.11▲ +0.57%▲ +0.48%$5.38 (−23.90%)
Aug 31, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$7.07 $7.11▲ +0.57%▲ +0.48%$5.38 (−23.90%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$7.27 $7.17▼ −1.38%▼ −1.64%$5.38 (−26.00%)
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$7.04 $7.27▲ +3.27%▲ +3.67%$5.38 (−23.58%)
Aug 5, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$7.06 $7.67▲ +8.64%▲ +8.29%$5.38 (−23.80%)
Aug 3, 2026
8w ago
Insider Cluster
NEUTRAL ★ 4/10
$7.24 $7.04▼ −2.76%▼ −2.66%$5.38 (−25.69%)
Jul 30, 2026
9w ago
144
BEARISH ★ 5/10
$6.79 $6.87▼ −1.18%▲ +2.33%$5.38 (+20.77%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (65h 6m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 3, 2026